MarketPeel
Insider Trading Intelligence
Pricing
…
DH

Douglas M. Hunt

PBYI
SEE REMARKS · PUMA BIOTECHNOLOGY, INC. · CIK 0001727172
FILING MIX · LIFETIME31%/69%
BUYS
17
SELLS
37
TOTAL VALUE
$439.7K
COMPANIES
1
ACTIVE SINCE
Jan 2020
HOLDINGS NOW
196,841
AVG SELL PX
$5.38
TRADE KIND
SHOWING 54 / 54
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
35 backtested trades · 8 horizons · 8 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Douglas M. Hunt, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d35+42.86%+3.88%-0.01%+3.89%+2.54%1.50
14d35+54.29%+2.14%-0.18%+2.32%-4.13%0.81
30d35+54.29%+0.79%+0.41%+0.38%-3.63%0.09
60d35+57.14%+0.73%+1.01%-0.28%-7.55%-0.05
90d35+65.71%-0.49%+1.09%-1.58%-6.53%-0.26
180d35+54.29%-1.35%+4.36%-5.71%-6.86%-0.70
1y35(2 pending)+48.48%+0.17%+8.59%-8.42%-12.62%-0.81
2y35(6 pending)+55.17%-1.04%+25.07%-26.11%-55.54%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
PBYI · 196,841 shares · as of Jul 6, 2026
051,325102,651153,976205,301202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 17 buys / 37 sellsCOVERAGE · 27 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
8,460$8.26$69.9K196,841Jul 6, 2026Jul 8, 2026 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
49,394——205,301Feb 18, 2026Feb 20, 2026 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
70,321——70,321Feb 18, 2026Feb 20, 2026 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
5,014$5.88$29.5K155,907Jan 7, 2026Jan 8, 2026 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
3,973$5.84$23.2K160,921Jan 6, 2026Jan 8, 2026 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
3,443$3.54$12.2K164,894Jul 9, 2025Jul 10, 2025 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
4,374$3.53$15.5K168,337Jul 8, 2025Jul 10, 2025 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
66,604——66,604Feb 7, 2025Feb 11, 2025 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
48,117——172,711Feb 7, 2025Feb 11, 2025 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
8,633$3.15$27.2K124,594Jan 2, 2025Jan 3, 2025 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
3,637$3.70$13.5K133,227Jul 17, 2024Jul 18, 2024 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
4,349$3.27$14.2K136,864Jul 2, 2024Jul 2, 2024 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
52,452——52,452Feb 12, 2024Feb 14, 2024 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
37,894——141,213Feb 12, 2024Feb 14, 2024 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE10b5-1
10b5-1 plan
8,358$4.49$37.5K103,319Jan 3, 2024Jan 5, 2024 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
48,136——119,486Feb 10, 2023Feb 14, 2023 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
66,864——66,864Feb 10, 2023Feb 14, 2023 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
4,225$4.18$17.7K71,350Jan 3, 2023Jan 5, 2023 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
429$4.50$1.9K75,575Dec 2, 2022Dec 6, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
429$2.25$96576,004Nov 2, 2022Nov 4, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
435$2.34$1.0K76,433Oct 3, 2022Oct 5, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
433$2.59$1.1K76,868Sep 2, 2022Sep 7, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
429$2.89$1.2K77,301Aug 2, 2022Aug 4, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
3,753$2.63$9.9K77,730Jul 5, 2022Jul 7, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
417$1.94$81181,483Jun 2, 2022Jun 6, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
438$2.31$1.0K81,900May 3, 2022May 5, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
413$3.08$1.3K82,338Apr 4, 2022Apr 5, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
22,647——82,751Mar 3, 2022Mar 14, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
32,353——32,353Mar 3, 2022Mar 14, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
446$2.26$1.0K60,104Mar 2, 2022Mar 4, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
533$2.47$1.3K60,550Feb 2, 2022Feb 3, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
3,707$3.21$11.9K61,083Jan 3, 2022Jan 5, 2022 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
441$2.90$1.3K64,790Dec 2, 2021Dec 6, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
427$5.64$2.4K65,231Nov 2, 2021Nov 3, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
443$6.15$2.7K65,658Oct 4, 2021Oct 6, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
422$7.52$3.2K66,101Sep 2, 2021Sep 3, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
420$7.53$3.2K66,523Aug 2, 2021Aug 3, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
1,016$9.15$9.3K66,943Jul 2, 2021Jul 6, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
416$10.77$4.5K67,959Jun 2, 2021Jun 4, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
417$9.91$4.1K68,375May 3, 2021May 5, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
426$9.80$4.2K68,792Apr 5, 2021Apr 6, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
422$10.16$4.3K69,218Mar 2, 2021Mar 4, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
19,757——69,640Feb 17, 2021Feb 24, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
27,793——27,793Feb 17, 2021Feb 24, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
19,757——69,640Feb 17, 2021Feb 19, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
27,793——27,793Feb 17, 2021Feb 19, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
412$12.27$5.1K49,883Feb 2, 2021Feb 3, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
6,463$10.23$66.1K50,295Jan 4, 2021Jan 6, 2021 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
572$10.69$6.1K56,758Jul 2, 2020Jul 6, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
1,728$10.25$17.7K52,830Feb 27, 2020Mar 2, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
4,500——57,330Feb 25, 2020Apr 6, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
54,842——54,842Feb 11, 2020Feb 13, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
PURCHASEGRANT
Stock grant
43,274——54,558Feb 11, 2020Feb 13, 2020 ↗View →
PBYI
PUMA BIOTECHNOLOGY, INC.
SALE
See Remarks
1,405$8.43$11.8K11,284Jan 2, 2020Jan 3, 2020 ↗View →
Other insiders · PBYI
Loading peer insiders…
About this filer
CIK 0001727172
ROLE
See Remarks
PRIMARY
PBYI
COMPANIES
1
ACTIVE SINCE
Jan 2020
MARKETPEEL · /INSIDER/0001727172DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback